Tetraethylene Glycol

Tetraethylene Glycol

SCHEMBL23356802

CCCCCCCOCCCCCC.OCCOCCOCCOCCO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 1.00
KMT2A Q03164 4/20 1.00
HTT P42858 2/20 1.00
THRB P10828 1/20 1.00
MAPT P10636 1/20 1.00
TSHR P16473 3/20 0.76
USP2 O75604 2/20 0.52
LMNA P02545 3/20 0.51
ALDH1A1 P00352 3/20 0.51
MAPK1 P28482 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
CYP3A4 P08684 1/20 0.51
CASP1 P29466 1/20 0.51
SLCO1B3 Q9NPD5 1/20 0.51
SLCO1B1 Q9Y6L6 1/20 0.51
CES2 O00748 2/20 0.50
HSD17B10 Q99714 1/20 0.50
CES1 P23141 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetraethylene Glycol SCHEMBL23356887 1.00 MEN1 (1.00) MEN1KMT2AHTTTHRBMAPT
Tetraethylene Glycol SCHEMBL23356867 1.00 MEN1 (1.00) MEN1KMT2AHTTTHRBMAPT
Tetraethylene Glycol SCHEMBL23356748 1.00 MEN1 (1.00) MEN1KMT2AHTTTHRBMAPT
Tetraethylene Glycol SCHEMBL23356845 1.00 MEN1 (1.00) MEN1KMT2AHTTTHRBMAPT
Triethylene Glycol SCHEMBL23356778 1.00 MEN1 (1.00) MEN1KMT2AHTTTHRBMAPT
Triethylene Glycol SCHEMBL23356768 1.00 MEN1 (1.00) MEN1KMT2AHTTTHRBMAPT
Triethylene Glycol SCHEMBL23356898 1.00 MEN1 (1.00) MEN1KMT2AHTTTHRBMAPT
Triethylene Glycol SCHEMBL23356780 1.00 MEN1 (1.00) MEN1KMT2AHTTTHRBMAPT
Tetraethylene Glycol SCHEMBL23356819 1.00 MEN1 (1.00) MEN1KMT2AHTTTHRBMAPT
Triethylene Glycol SCHEMBL23356745 1.00 MEN1 (1.00) MEN1KMT2AHTTTHRBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12597635-B2 Electrochemical device MURATA MANUFACTURING CO., LTD. (JP) 2026-04-07 US disclosed
CN-116918095-A Positive electrode and electrochemical device 株式会社村田制作所 2023-10-20 CN disclosed
US-20230223525-A1 ELECTROCHEMICAL DEVICE MURATA MANUFACTURING CO., LTD. (JP) 2023-07-13 US disclosed
CN-116250124-A Electrochemical device 株式会社村田制作所 2023-06-09 CN disclosed
EP-3832772-A1 ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL DEVICE Murata Manufacturing Co., Ltd. (JP) 2021-06-09 EP disclosed
US-20210151803-A1 ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL DEVICE MURATA MANUFACTURING CO., LTD. (JP) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12597635-B2 Electrochemical device CLCN2, HCN4, SLC26A3 MEN1 1871/4885KMT2A 2323/4885HTT 3183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.